Mereo BioPharma Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	40	49	433	254	73	128
Market Cap Growth	-86.79%	-88.62%	70.57%	249.41%	-43.41%	-27.46%
Enterprise Value	9	13	374	221	14	37
Last Close Price	0.24	0.27	2.76	1.85	0.62	1.20
PE Ratio	-	-	-	-	-	10.09
PS Ratio	106.40	132.62	-	32.34	-	3.52
PB Ratio	1.30	1.62	8.89	6.40	1.70	1.46
P/TBV Ratio	1.32	1.64	8.99	6.54	1.70	2.02
EV/Sales Ratio	23.48	36.02	-	28.17	-	1.02
Debt / Equity Ratio	0.01	0.01	0.11	0.12	0.30	0.19
Net Debt / Equity Ratio	-1.00	-1.00	-1.04	-1.02	-1.03	-0.88
Net Debt / EBITDA Ratio	1.08	1.08	1.40	1.94	1.01	3.72
Net Debt / FCF Ratio	1.32	1.32	1.93	2.44	1.08	13.43
Asset Turnover	0.01	0.01	-	0.14	-	0.39
Quick Ratio	9.99	9.99	5.28	6.45	2.89	7.66
Current Ratio	10.47	10.47	5.40	6.72	3.09	7.92
Return on Equity (ROE)	-82.21%	-82.21%	-77.58%	-57.81%	-53.63%	34.85%
Return on Assets (ROA)	-39.41%	-39.41%	-39.99%	-23.57%	-28.67%	-13.82%
Return on Invested Capital (ROIC)	-	-	-	-	-825.95%	-
Return on Capital Employed (ROCE)	-92.70%	-92.70%	-73.10%	-47.60%	-99.40%	-18.40%
Earnings Yield	-78.72%	-63.15%	-7.98%	-9.11%	-48.22%	9.91%
FCF Yield	-58.25%	-46.74%	-6.06%	-6.54%	-55.78%	-4.50%
Buyback Yield / Dilution	-7.77%	-7.77%	-12.16%	-9.33%	-8.63%	-63.82%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.